felin
coronavirus
fcov
vari
wide
virul
caus
spectrum
clinic
manifest
reach
subclin
cours
fatal
felin
infecti
periton
fip
independ
virul
variat
separ
two
differ
type
type
origin
fcov
type
ii
close
relat
canin
coronaviru
ccv
preval
fcov
type
austrian
cat
popul
without
fip
survey
recent
indic
type
infect
predomin
distribut
fcov
type
cat
succumb
fip
howev
fairli
unknown
pcr
assay
develop
amplifi
part
spike
protein
gene
typespecif
primer
pair
design
gener
pcr
product
differ
size
total
organ
pool
cat
histopatholog
verifi
fip
test
clear
differenti
achiev
cat
type
posit
type
ii
posit
posit
type
find
demonstr
fip
case
fcov
type
predomin
nonetheless
case
fcov
type
ii
detect
suggest
caus
involv
case
fip
felin
infecti
periton
fip
fatal
immunemedi
diseas
domest
wild
feet
al
wege
et
al
barlough
et
al
show
infect
ccv
caus
seroconvers
clinic
sign
cat
examin
neither
cours
subsequ
experiment
induc
fip
diseas
sever
contrast
find
mcardl
et
al
demonstr
infect
ccv
cours
fip
diseas
sever
ccv
induc
cat
similar
symptom
dog
furthermor
one
ccv
strain
caus
cat
clinic
symptom
discern
fip
import
ccv
cat
remain
uncertain
spark
et
al
two
biolog
type
fcov
known
felin
infecti
periton
viru
fipv
felin
enter
coronaviru
fecv
pedersen
pedersen
pedersen
pedersen
et
al
genom
fecv
strain
prove
kb
shorter
suggest
delet
bp
end
vennema
et
al
molecular
studi
show
fipv
aris
mutat
fecv
pedersen
et
al
evermann
et
al
poland
et
al
herrewegh
et
al
vennema
et
al
vennema
et
al
fipv
fecv
may
depend
virul
caus
viremia
herrewegh
et
al
fehr
et
al
gunnmoor
et
al
horzinek
fcov
separ
two
differ
type
base
upon
growth
abil
vitro
antigen
relationship
ccv
neutralis
reactiv
sproteinspecif
mab
fiscu
teramoto
b
hohdatsu
et
al
hohdatsu
et
al
upon
sequenc
analysi
sprotein
gene
motokawa
et
al
type
show
littl
replic
cell
cultur
fipv
yayoi
dahlberg
fecv
ucd
type
ii
induc
lytic
cytopath
effect
fipv
fecv
abil
fcov
strain
propag
cell
cultur
correl
virul
vivo
mochizuki
et
al
among
fcov
type
ii
fipv
fecv
strain
repres
sprotein
gene
type
ii
close
relat
tgev
ccv
show
similar
nucleotid
sequenc
respect
sprotein
gene
type
motokawa
et
al
herrewegh
et
al
demonstr
fcov
type
ii
result
recombin
fcov
type
ccv
recent
studi
indic
type
ii
use
felin
aminopeptidas
n
fapn
cellsurfac
metalloproteas
intestin
lung
kidney
epitheli
cell
receptor
fapn
may
also
bind
ccv
tgev
hcv
clear
whether
receptor
specif
type
ii
play
role
pathogenesi
patholog
alter
fip
william
et
al
de
groot
horzinek
hohdatsu
et
al
tresnan
holm
preval
type
ii
survey
two
studi
austria
japan
respect
suggest
major
fcov
infect
due
type
hohdatsu
et
al
posch
et
al
posch
et
al
fcov
ubiquit
cat
popul
highli
infecti
oronas
rout
therefor
endem
multicat
household
catteri
shelter
investig
show
high
percentag
cat
without
fip
symptom
expos
environ
posit
fcov
infect
seroposit
virem
excret
viru
faec
addi
jarrett
spark
et
al
herrewegh
et
al
foley
et
al
b
gunnmoor
et
al
posch
et
al
posch
et
al
found
seroposit
cat
austrian
cat
popul
without
sign
fip
cat
test
posit
fcov
nucleic
acid
blood
strong
evid
exist
persist
chronic
infect
viru
persist
intestin
organ
healthi
cat
asymptomat
carrier
may
excret
viru
period
month
even
year
foley
et
al
herrewegh
et
al
herrewegh
et
al
asymptomat
carrier
shedder
repres
coronaviru
reservoir
therefor
main
problem
prevent
fip
multicat
environ
addi
jarrett
b
addi
et
al
addi
et
al
foley
et
al
b
herrewegh
et
al
approxim
seroposit
cat
develop
fip
highest
incid
cat
month
year
age
major
case
occur
cat
year
age
scott
addi
jarrett
higher
incid
fip
among
purebr
cat
scott
cheetah
evermann
et
al
cat
fipsuscept
bloodlin
may
indic
genet
predisposit
addit
sex
host
may
influenc
outbreak
diseas
pedersen
found
gener
disposit
potkay
et
al
binder
hartmann
observ
higher
incid
fip
among
male
among
femal
although
serolog
test
immunofluoresc
assay
ifa
moestl
elisa
mochizuki
furukawa
help
tool
fip
diagnosi
result
interpret
correl
clinic
symptom
spark
et
al
present
conclus
fip
diagnosi
establish
histopatholog
examin
biopsi
post
mortem
materi
recent
develop
revers
transcriptas
polymeras
chain
reaction
rtpcr
assay
use
primer
target
highli
conserv
region
viral
genom
utr
untransl
region
herrewegh
et
al
fehr
et
al
sprotein
gene
li
scott
gambl
et
al
common
fcov
strain
becam
valuabl
tool
detect
fcov
nucleic
acid
blood
bodi
caviti
effus
faec
tissu
sampl
infect
cat
particular
ntermin
domain
sprotein
gene
allow
differenti
two
type
ii
posch
et
al
posch
et
al
develop
rtpcr
use
primer
target
sprotein
gene
studi
preval
two
fcov
type
cat
without
fip
symptom
show
pcrposit
cat
prove
posit
type
type
ii
type
retrospect
studi
present
investig
preval
two
type
fcov
cat
histopatholog
verifi
fip
use
nest
seminest
rtpcr
assay
primer
target
well
sprotein
gene
aim
studi
investig
distribut
two
fcov
type
fip
diseas
cat
furthermoresinc
fcov
type
ii
may
use
differ
receptorsw
want
investig
whether
two
type
associ
differ
clinic
cours
diseas
andor
distinct
histopatholog
chang
final
intend
get
inform
import
ccv
cat
ccv
may
infect
cat
may
involv
indirectli
regard
possibl
recombin
fcov
type
ccv
may
happen
field
time
horzinek
total
cat
examin
institut
patholog
forens
veterinari
medicin
univers
veterinari
medicin
vienna
cat
diagnos
fip
analysi
breed
gender
age
cat
fip
compar
cat
without
fip
symptom
shown
tabl
statist
evalu
paramet
breed
gender
age
two
group
cat
fip
cat
without
fip
carri
test
use
program
spss
ms
window
version
cat
histopatholog
confirm
fip
organ
sampl
lung
liver
spleen
kidney
gut
avail
either
formalinfix
paraffinembed
tissu
pet
n
fresh
organ
sampl
n
pet
sampl
fix
buffer
formaldehyd
h
embed
paraffin
fresh
organ
sampl
taken
section
either
process
immedi
store
c
use
prepar
pet
sampl
carri
essenti
describ
sorg
metzler
four
six
thick
section
paraffinembed
organ
cat
pool
deparaffinis
incub
min
xylen
wash
twice
min
ethanol
room
temperatur
centrifug
air
dri
min
c
l
proteinas
k
l
depend
sampl
size
buffer
atl
qiagen
valencia
ca
usa
ad
sampl
incub
c
day
necessari
anoth
equival
proteinas
k
buffer
atl
ad
second
third
day
incub
inactiv
proteinas
k
c
min
centrifug
rna
extract
upper
aqueou
phase
use
commerci
avail
kit
qiaamp
viral
rna
mini
kit
qiagen
valencia
ca
usa
extract
store
c
one
three
gram
organ
sampl
pool
homogenis
steril
sand
resuspend
ml
diethyl
pyrocarbon
depc
treat
water
centrifug
rna
gener
screen
fcov
carri
rtand
nest
n
pcr
describ
herrewegh
et
al
use
primer
rtpcr
npcr
respect
sampl
posit
assay
submit
analysi
employ
oligonucleotid
primer
design
region
sprotein
gene
allow
differenti
fcov
type
ii
improv
sensit
pcr
assay
second
round
amplif
npcr
primer
b
seminest
primer
carri
follow
rtpcr
primer
select
help
primer
design
program
scientif
educ
softwar
version
shown
tabl
rtpcr
carri
singletub
assay
reaction
volum
l
l
pcr
mixtur
l
templat
use
commerci
avail
kit
access
rtpcr
system
promega
madison
wi
usa
mgso
concentr
optimis
mm
use
primer
respect
neg
sampl
retest
employ
one
step
rtpcr
kit
qiagen
valencia
ca
usa
cycler
scheme
carri
follow
instruct
manufactur
amount
l
rtpcr
product
ad
l
master
mix
npcr
seminest
pcr
respect
contain
mm
trishcl
ph
c
mm
kcl
triton
deoxynucleosid
triphosph
mm
mgcl
u
taq
polymeras
pm
primer
fortyf
cycl
denatur
c
primer
anneal
c
primer
extens
c
employ
possibl
fals
posit
result
due
carryov
amplif
product
particular
npcr
rule
number
precaut
taken
minimis
risk
contamin
includ
physic
separ
pcr
procedur
use
least
four
neg
control
rnase
free
water
assay
three
primer
pair
sampl
rtpcr
amplif
product
ad
master
mix
npcr
laboratori
specif
instal
purpos
final
sequenc
analysi
amplif
product
serv
addit
control
twenti
microlitr
pcr
product
analys
electrophoresi
agaros
gel
h
min
v
visualis
ethidium
bromid
stain
bp
ladder
amersham
pharmacia
biotech
inc
piscataway
nj
usa
serv
molecular
weight
marker
band
visualis
uv
illumin
photograph
use
eagl
eye
tm
ii
uv
gel
imag
system
stratagen
la
jolla
ca
usa
sequenc
analysi
perform
gel
extract
amplifi
product
qia
quick
gel
extract
kit
qiagen
valencia
ca
usa
sequenc
pcr
abi
prism
big
dye
tm
termin
cycl
sequenc
readi
reaction
kit
perkin
elmer
alameda
ca
usa
use
sequenc
analys
abi
prism
genet
analys
pe
appli
biosystem
partial
nucleotid
sequenc
stretch
bp
within
sprotein
gene
region
select
type
type
ii
posit
sampl
well
one
five
sampl
test
posit
type
determin
align
shown
fig
extract
cell
cultur
supernat
five
differ
fcovstrain
type
fipv
fipv
type
ii
fipv
fecv
fipv
submit
rtpcr
nest
seminest
pcr
employ
primer
gel
extract
strain
fipv
fipv
contain
pmoll
dna
respect
obtain
rtpcr
primer
dilut
rnase
free
water
concentr
trna
serv
templat
npcr
far
antibodi
titr
record
case
histori
compar
pcr
result
result
patholog
examin
analys
accord
follow
criteria
section
presenc
amount
fip
typic
effus
low
medium
high
amount
fip
suspici
granuloma
pyogranuloma
granuloma
ye
localis
record
subsequ
histopatholog
examin
confirm
diagnosi
fip
presenc
typic
vascul
central
necrosi
perivascular
infiltr
plasma
cell
macrophag
lymphocyt
neutrophil
gener
data
fipdiseas
cat
analys
compar
cat
without
fip
symptom
examin
period
time
institut
patholog
forens
veterinari
medicin
univers
veterinari
medicin
vienna
tabl
statist
examin
show
incid
fip
significantli
higher
among
male
versu
femal
p
among
purebr
versu
domest
short
hair
cat
p
among
young
anim
year
p
significantli
greater
number
male
among
fipdiseas
cat
found
age
categori
year
p
cat
older
year
trend
could
observ
p
pet
sampl
test
neg
nucleic
acid
could
detect
fresh
organ
sampl
primer
describ
herrewegh
et
al
differenti
two
type
accomplish
pet
sampl
test
posit
fcov
pcr
result
one
addit
sampl
question
fresh
organ
sampl
one
addit
question
result
total
differenti
possibl
sampl
among
test
posit
type
type
ii
type
ii
tabl
sampl
posit
type
test
posit
primer
primer
pair
primer
sampl
question
pcr
result
test
question
posit
primer
pair
neg
primer
second
one
vice
versa
sampl
posit
type
ii
test
posit
employ
primer
use
primer
result
alreadi
achiev
rtpcr
extract
cell
cultur
supernat
five
differ
fcov
strain
type
strain
fipv
fipv
type
ii
strain
fipv
fecv
fipv
subject
rtpcr
nest
seminest
pcr
primer
pair
employ
primer
type
strain
show
amplif
product
estim
size
wherea
type
ii
strain
test
neg
fig
primer
primer
strain
test
posit
wherea
type
strain
remain
neg
fig
primer
gel
extract
strain
fipv
fipv
obtain
rtpcr
primer
pair
test
posit
nest
pcr
assay
dilut
respect
antibodi
titr
fcov
known
case
histori
cat
titr
indic
serolog
neg
group
cat
fcov
antibodi
titr
twelv
test
posit
fcov
nucleic
acid
type
neg
type
ii
one
posit
type
ii
neg
type
seven
cat
differenti
two
type
could
achiev
three
cat
titr
test
posit
type
neg
type
ii
singl
cat
titr
seroneg
cat
test
neg
fcov
nucleic
acid
partial
nucleotid
sequenc
sprotein
gene
type
type
ii
posit
sampl
well
one
sampl
posit
type
determin
sequenc
compil
result
readabl
stretch
bp
align
use
sequenc
type
strain
fipv
refer
align
also
correspond
sequenc
fcov
type
ii
refer
strain
ccv
refer
strain
includ
analysi
sampl
reveal
nucleotid
ident
type
specimen
type
ii
sampl
respect
refer
type
strain
fipv
fig
type
ii
specimen
refer
ccv
strain
histopatholog
examin
exhibit
differ
relat
type
fcov
detect
type
found
effus
noneffus
fip
well
case
sign
form
statist
evalu
possibl
due
small
number
type
ii
posit
sampl
comparison
two
group
cat
fip
n
cat
without
fip
symptom
n
examin
year
institut
patholog
forens
veterinari
medicin
veterinari
univers
vienna
show
signific
differ
statist
evalu
use
test
paramet
breed
gender
age
two
group
show
incid
fip
significantli
higher
among
purebr
cat
male
among
cat
year
age
younger
percentag
purebr
cat
fipdiseas
cat
twice
high
compar
group
versu
p
find
sustain
earlier
studi
pedersen
foley
pedersen
observ
higher
suscept
fip
purebr
cat
first
degre
rel
succumb
fip
due
inbreed
genet
predisposit
may
evolv
certain
breed
cat
may
allow
fcov
propag
effici
cat
cat
wider
genet
histori
group
cat
fip
major
male
femal
although
compar
group
percentag
male
slightli
higher
well
male
versu
femal
differ
group
signific
p
find
contrast
pedersen
find
sexual
predisposit
accord
potkay
et
al
binder
hartmann
also
report
higher
incid
fip
among
male
major
cat
fip
younger
compar
group
age
class
addi
jarrett
found
well
scott
higher
incid
fip
cat
year
compar
incid
male
femal
age
group
year
older
year
cat
without
fip
found
among
younger
cat
incid
male
significantli
higher
cat
fip
compar
group
role
sexspecif
differ
immun
system
particular
cell
mediat
immun
import
factor
neuter
anim
hormon
influenc
still
clear
total
sampl
fcov
nucleic
acid
could
detect
six
pet
sampl
test
neg
wherea
fresh
organ
sampl
test
posit
respect
expect
lower
rna
concentr
pet
due
formalin
fixat
procedur
one
hand
due
long
storag
time
year
hand
chose
primer
amplifi
compar
employ
posch
et
al
posch
et
al
smaller
segment
viral
genom
primer
achiev
differenti
two
type
pet
specimen
fresh
organ
sampl
addit
two
sampl
exhibit
question
pcr
result
expect
percentag
posit
pcr
result
lower
pet
sampl
fresh
organ
sampl
specif
test
five
differ
fcov
strain
four
differ
primer
pair
fig
primer
fecvb
found
fals
posit
result
amplif
product
show
band
expect
size
despit
use
differ
primer
pair
sampl
pcr
remain
neg
probabl
due
variabl
sprotein
gene
fcov
oligonucleotid
primer
employ
pcr
assay
exhibit
high
sensit
primer
prove
amplifi
specif
nucleic
acid
dilut
primer
show
amplif
even
dilut
sinc
origin
rna
concentr
similar
sampl
find
indic
higher
sensit
detect
type
ii
virus
thu
sampl
differenti
pcr
unsuccess
fcov
type
may
predomin
well
hand
due
lower
sensit
type
pcr
exclud
caus
involv
type
type
ii
posit
cat
sampl
differenti
achiev
test
posit
type
type
ii
type
ii
thu
identifi
type
caus
agent
major
fip
case
examin
wherea
posch
et
al
posch
et
al
identifi
type
ii
includ
sampl
type
fcovposit
cat
without
fip
symptom
found
type
ii
cat
fip
involv
among
show
doubl
infect
type
ii
find
contrast
result
hohdatsu
et
al
japanes
cat
none
healthi
cat
test
posit
type
ii
wherea
among
chronic
diseas
cat
without
fip
symptom
among
fipdiseas
cat
even
infect
fcov
type
ii
due
close
antigen
relationship
sprotein
gene
need
choos
primer
region
possibl
differenti
two
fcov
type
infect
ccv
would
also
detect
data
shown
therefor
caus
involv
ccv
type
ii
posit
fip
case
rule
studi
import
ccv
cat
still
remain
unclear
barlough
et
al
mcardl
et
al
possibl
recombin
fcov
type
ccv
horzinek
requir
investig
particular
role
ccv
doubl
infect
fcov
type
observ
especi
multicat
household
temperaturesensit
fipv
strain
use
fip
vaccin
type
ii
strain
fipv
regard
fact
major
fip
case
examin
due
type
question
aris
whether
fact
contribut
observ
vaccin
failur
whether
inclus
also
type
strain
vaccin
consid
sequenc
result
show
even
short
region
sequenc
clear
discrimin
fcov
type
fcov
type
ii
ccv
strain
fig
partial
sequenc
austrian
fcov
type
sampl
show
signific
differ
compar
refer
strain
result
ident
rate
refer
strain
also
within
austrian
fcov
type
sampl
sever
nucleotid
chang
notic
indic
quit
high
mutat
rate
fcov
type
ii
sampl
form
group
ident
fcov
type
refer
strain
respect
ccv
exhibit
ident
much
closer
relationship
fcov
type
ii
fcov
type
nice
observ
similar
sever
nucleotid
chang
fcov
type
ii
ccv
find
support
observ
fcov
type
ii
may
aris
recombin
ccv
nonetheless
ccv
also
exhibit
sever
uniqu
nucleotid
chang
sequenc
data
one
five
sampl
show
doubl
infect
fig
demonstr
clearli
plausabl
coinfect
among
cat
known
antibodi
titr
cat
posit
fcov
nucleic
acid
show
antibodi
titr
higher
neither
section
histopatholog
examin
differ
relat
fcov
type
detect
could
identifi
group
type
posit
cat
show
sign
form
effus
noneffus
fip
follow
noneffus
effus
fip
type
ii
posit
sampl
form
fip
repres
well
find
point
toward
pathogenet
import
receptorspecif
type
ii
hohdatsu
et
al
emphasis
role
immun
respons
genet
predisposit
individu
outbreak
diseas
find
suggest
involv
fcov
type
fip
accord
earlier
report
type
fcov
abl
caus
fip
also
correl
result
obtain
healthi
fcovinfect
cat
support
predomin
fcov
type
infect
fcovinfect
healthi
fipdiseas
cat
fcov
type
ii
probabl
recombin
type
canin
coronaviru
involv
fip
case
investig
assum
recombin
occur
field
therefor
contact
dog
excret
canin
coronaviru
may
play
role
emerg
new
type
ii
fcov
howev
sampl
posit
fcov
type
ii
need
investig
respect
relationship
even
differenti
ccv
special
interest
also
paid
cat
doubl
infect
concern
role
field
infect
ccv
role
develop
fip
final
differ
histopatholog
chang
found
relat
fcov
type
detect
